4 x Epirubicin, Cyclophosphamide, Followed by 4 x Docetaxel Versus 6 x CMF / 6 x CEF
Clinical trial NCT02115204 · COMPLETED
Trial details
- NCT number
- NCT02115204
- Sponsor
- Women's Cancer Study Group GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2000-06-01
- Primary completion
- 2005-08-01
- Enrollment
- 2011
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.